Glucose Transporter 1 Promotes the Malignant Phenotype of Non-Small Cell Lung Cancer through Integrin β 1/Src/FAK Signaling

Conclusion: Taken together, our data confirms that GLUT1 promotes the malignant phenotype of NSCLC through integrin β1/Src/FAK signaling, which provides a new therapeutic target for the treatment and research of lung cancer.

Source: Journal of Cancer - December 14, 2019 Category: Cancer & Oncology Authors: Huanyu Zhao, Jian Sun, Jianshuang Shao, Zifang Zou, Xueshan Qiu, Enhua Wang, Guangping Wu Tags: Research Paper Source Type: research